Filing Flows › Lucid Diagnostics (LUCD) › Who owns the stock
Who owns Lucid Diagnostics (LUCD) stock
109 funds reported Lucid Diagnostics (LUCD) shares in their latest 13F filings, worth $69.5M in all. The largest holder is Alyeska Investment Group, L.P. ($9.5M). Last quarter 59 funds added to their stakes and 36 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Alyeska Investment Group, L.P. | 8,856,844 | $9.5M | new | 2026-06-30 |
| BlackRock | 8,373,117 | $9.0M | increase | 2026-06-30 |
| Vanguard Capital Management LLC | 6,556,344 | $7.0M | increase | 2026-06-30 |
| Vanguard Group | 4,968,608 | $5.4M | increase | 2025-12-31 |
| Two Seas Capital LP | 6,000,000 | $4.5M | unchanged | 2026-09-30 |
| Masters Capital Management LLC | 4,000,000 | $4.3M | unchanged | 2026-06-30 |
| abrdn | 3,822,997 | $4.1M | increase | 2026-06-30 |
| Geode Capital Management, LLC | 3,789,948 | $4.1M | increase | 2026-06-30 |
| State Street | 2,437,337 | $2.6M | increase | 2026-06-30 |
| First Manhattan Co. LLC. | 2,188,550 | $2.3M | increase | 2026-06-30 |
| Wells Fargo | 2,067,046 | $2.2M | increase | 2026-06-30 |
| Russell Investments Group | 1,651,788 | $1.8M | increase | 2026-06-30 |
| Northern Trust | 1,219,879 | $1.3M | increase | 2026-06-30 |
| Vanguard Fiduciary Trust | 1,068,109 | $1.1M | increase | 2026-06-30 |
| Vanguard Portfolio Management LLC | 1,022,262 | $1.1M | increase | 2026-06-30 |
Lucid Diagnostics' latest quarter
Lucid Diagnostics, Q2 2026: revenue $1.5M (+27% year over year), operating margin -868.5%, net loss $11.7M, operating cash flow −$11.3M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most LUCD stock?
By the latest 13F filings: Alyeska Investment Group, L.P. ($9.5M); BlackRock ($9.0M); Vanguard Capital Management LLC ($7.0M); Vanguard Group ($5.4M); Two Seas Capital LP ($4.5M).
What is the short interest in LUCD?
13,630,379 shares were sold short at the 2026-10-15 settlement, 1.3% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.